363 related articles for article (PubMed ID: 27400883)
1. The triptolide derivative MRx102 inhibits Wnt pathway activation and has potent anti-tumor effects in lung cancer.
Reno TA; Tong SW; Wu J; Fidler JM; Nelson R; Kim JY; Raz DJ
BMC Cancer; 2016 Jul; 16():439. PubMed ID: 27400883
[TBL] [Abstract][Full Text] [Related]
2. Triptolide Inhibits Lung Cancer Cell Migration, Invasion, and Metastasis.
Reno TA; Kim JY; Raz DJ
Ann Thorac Surg; 2015 Nov; 100(5):1817-24; discussion 1824-5. PubMed ID: 26298168
[TBL] [Abstract][Full Text] [Related]
3. Triptolide inhibits Wnt signaling in NSCLC through upregulation of multiple Wnt inhibitory factors via epigenetic modifications to Histone H3.
Nardi I; Reno T; Yun X; Sztain T; Wang J; Dai H; Zheng L; Shen B; Kim J; Raz D
Int J Cancer; 2018 Nov; 143(10):2470-2478. PubMed ID: 30006924
[TBL] [Abstract][Full Text] [Related]
4. Wnt inhibitory factor-1-mediated autophagy inhibits Wnt/β-catenin signaling by downregulating dishevelled-2 expression in non-small cell lung cancer cells.
Luo X; Ye S; Jiang Q; Gong Y; Yuan Y; Hu X; Su X; Zhu W
Int J Oncol; 2018 Aug; 53(2):904-914. PubMed ID: 29916529
[TBL] [Abstract][Full Text] [Related]
5. Triptolide exhibits antitumor effects by reversing hypermethylation of WIF‑1 in lung cancer cells.
Mao X; Tong J; Wang Y; Zhu Z; Yin Y; Wang Y
Mol Med Rep; 2018 Sep; 18(3):3041-3049. PubMed ID: 30015908
[TBL] [Abstract][Full Text] [Related]
6. Triptolide enhances chemotherapeutic efficacy of antitumor drugs in non-small-cell lung cancer cells by inhibiting Nrf2-ARE activity.
Zhu J; Wang H; Chen F; Lv H; Xu Z; Fu J; Hou Y; Xu Y; Pi J
Toxicol Appl Pharmacol; 2018 Nov; 358():1-9. PubMed ID: 30196066
[TBL] [Abstract][Full Text] [Related]
7. Preclinical antileukemic activity, toxicology, toxicokinetics and formulation development of triptolide derivative MRx102.
Fidler JM; An J; Carter BZ; Andreeff M
Cancer Chemother Pharmacol; 2014 May; 73(5):961-74. PubMed ID: 24619497
[TBL] [Abstract][Full Text] [Related]
8. miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1.
Zhang H; Hu B; Wang Z; Zhang F; Wei H; Li L
Cancer Chemother Pharmacol; 2017 Nov; 80(5):973-984. PubMed ID: 28956120
[TBL] [Abstract][Full Text] [Related]
9. [Advances on effects of triptolide with non-small cell lung cancer].
Wang L; Song Y
Zhongguo Fei Ai Za Zhi; 2013 Jul; 16(7):378-81. PubMed ID: 23866670
[TBL] [Abstract][Full Text] [Related]
10. Targeted inhibition of the HNF1A/SHH axis by triptolide overcomes paclitaxel resistance in non-small cell lung cancer.
Li LB; Yang LX; Liu L; Liu FR; Li AH; Zhu YL; Wen H; Xue X; Tian ZX; Sun H; Li PC; Zhao XG
Acta Pharmacol Sin; 2024 May; 45(5):1060-1076. PubMed ID: 38228910
[TBL] [Abstract][Full Text] [Related]
11. MRx102, a triptolide derivative, has potent antileukemic activity in vitro and in a murine model of AML.
Carter BZ; Mak DH; Shi Y; Fidler JM; Chen R; Ling X; Plunkett W; Andreeff M
Leukemia; 2012 Mar; 26(3):443-50. PubMed ID: 21904380
[TBL] [Abstract][Full Text] [Related]
12. KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models.
Kenessey I; Kói K; Horváth O; Cserepes M; Molnár D; Izsák V; Dobos J; Hegedűs B; Tóvári J; Tímár J
Oncotarget; 2016 Nov; 7(48):79503-79514. PubMed ID: 27780929
[TBL] [Abstract][Full Text] [Related]
13. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
[TBL] [Abstract][Full Text] [Related]
14. Curcumin sensitizes human lung cancer cells to apoptosis and metastasis synergistically combined with carboplatin.
Kang JH; Kang HS; Kim IK; Lee HY; Ha JH; Yeo CD; Kang HH; Moon HS; Lee SH
Exp Biol Med (Maywood); 2015 Nov; 240(11):1416-25. PubMed ID: 25716014
[TBL] [Abstract][Full Text] [Related]
15. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
Pang L; Han S; Jiao Y; Jiang S; He X; Li P
Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor activity of three ginsenoside derivatives in lung cancer is associated with Wnt/β-catenin signaling inhibition.
Bi X; Xia X; Mou T; Jiang B; Fan D; Wang P; Liu Y; Hou Y; Zhao Y
Eur J Pharmacol; 2014 Nov; 742():145-52. PubMed ID: 25199964
[TBL] [Abstract][Full Text] [Related]
17. Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70.
Zhou Y; Ma J; Zhang J; He L; Gong J; Long C
Oncol Rep; 2017 Jan; 37(1):313-322. PubMed ID: 28004121
[TBL] [Abstract][Full Text] [Related]
18. Triptolide reduces proliferation and enhances apoptosis of human non-small cell lung cancer cells through PTEN by targeting miR-21.
Li X; Zang A; Jia Y; Zhang J; Fan W; Feng J; Duan M; Zhang L; Huo R; Jiao J; Zhu X
Mol Med Rep; 2016 Mar; 13(3):2763-8. PubMed ID: 26847601
[TBL] [Abstract][Full Text] [Related]
19. Triptolide induces apoptosis through the calcium/calmodulin‑dependent protein kinase kinaseβ/AMP‑activated protein kinase signaling pathway in non‑small cell lung cancer cells.
Ren T; Tang YJ; Wang MF; Wang HS; Liu Y; Qian X; Chang C; Chen MW
Oncol Rep; 2020 Nov; 44(5):2288-2296. PubMed ID: 33000264
[TBL] [Abstract][Full Text] [Related]
20. Triptolide suppresses the growth and metastasis of non-small cell lung cancer by inhibiting β-catenin-mediated epithelial-mesenchymal transition.
Deng QD; Lei XP; Zhong YH; Chen MS; Ke YY; Li Z; Chen J; Huang LJ; Zhang Y; Liang L; Lin ZX; Liu Q; Li SP; Yu XY
Acta Pharmacol Sin; 2021 Sep; 42(9):1486-1497. PubMed ID: 33893396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]